AI-generated from publicly available materials.Radar Healthcare's recent acquisition of Cemplicity signifies a pivotal shift in the HealthTech landscape, aiming to unify patient experience with operational governance.
On August 12, 2026, Radar Healthcare announced its acquisition of Cemplicity, a platform specializing in patient-reported outcomes and experiences. This move, supported by Marlin Equity Partners, is part of Radar's broader strategy to enhance its offerings in risk and compliance management within healthcare. This acquisition follows Radar's earlier purchase of EIDO Healthcare, illustrating a commitment to expanding its capabilities in the healthcare technology sector.
The integration of Cemplicity's tools, including Patient-Reported Experience Measures (PREMs) and Patient-Reported Outcome Measures (PROMs), into Radar's existing frameworks aims to bridge the gap between patient feedback and operational governance. Traditionally, patient insights and clinical risk management have operated in silos, but this strategic alignment seeks to create a cohesive ecosystem that allows for proactive quality improvements. By automating the connection between patient experiences and risk management workflows, healthcare providers can respond more swiftly to potential issues, enhancing overall patient care.
This acquisition not only strengthens Radar Healthcare's service portfolio but also expands its geographic reach, particularly into Australia and New Zealand, where Cemplicity has established operations. The combined strengths of these platforms are expected to facilitate improved healthcare outcomes and operational efficiencies, ultimately driving a more integrated approach to patient care and governance in the industry.